| Vendor | Compound |
|---|
| Batch # |
|---|
| Purity |
|---|
| Date |
|---|
| Test Type |
|---|
| HelixBridge | Tesamorelin10mg | PPA-MB-TS10-66000616 | 99.223% | 07/31/2026 | ID + Purity + Mass |
| HelixBridge | Reta60mg | PPA-MB-R60-18020508 | 99.468% | 07/30/2026 | ID + Purity + Mass |
| HelixBridge | Tirze60mg | PPA-MB-T60-18130513 | 99.576% | 07/30/2026 | ID + Purity + Mass |
| Lumira | GHK-Cu50mg | PPA-WL-CU50-P00705 | 99.8% | 07/30/2026 | ID + Purity + Mass |
| Lumira | CJC-1295 (no DAC)5mg | PPA-WL-CND5-P00707 | 99.7% | 07/27/2026 | ID + Purity + Mass |
| Lumira | KLOW80mg | PPA-WL-KLOW-P00630 | 99.5% | 07/27/2026 | ID + Purity + Mass |
| Lumira | KPV10mg | PPA-WL-KPV10-P00704 | 99.2% | 07/27/2026 | ID + Purity + Mass |
| Lumira | PT-14110mg | PPA-WL-PT141-P00706 | 99.1% | 07/27/2026 | ID + Purity + Mass |
| Hang Sciences | Tirze20mg•User Submitted | — | 99.9% | 07/21/2026 | ID + Purity + Mass |
| Lumira | Ipamorelin10mg | PPA-WL-IP10-P00704 | 99.5% | 07/21/2026 | ID + Purity + Mass |
| Lumira | NAD+500mg | PPA-WL-NJ500-P00630 | 99.7% | 07/21/2026 | ID + Purity + Mass |
| Lumira | Reta5mg | PPA-WL-RT5-P00701 | 99.8% | 07/21/2026 | ID + Purity + Mass |
| HelixBridge | Tirze10mg•User Submitted | — | 99.09% | 07/20/2026 | ID + Purity + Mass |
| Lumira | MOTS-c40mg•User Submitted | WL-MS40-000299 | 99.506% | 07/20/2026 | ID + Purity + Mass |
| Lumira | Reta30mg•User Submitted | WL-RT30-000298 | 99.338% | 07/20/2026 | ID + Purity + Mass |
| Retalux | Reta60mg•User Submitted | — | 99.9% | 07/20/2026 | ID + Purity + Mass · Endotoxin |
| Retalux | Reta30mg•User Submitted | — | 99.6% | 07/20/2026 | ID + Purity + Mass · Endotoxin · Heavy Metals |
| Lumira | BPC-15710mg | PPA-WL-BC10-P00704 | 99.8% | 07/19/2026 | ID + Purity + Mass |
| Lumira | MOTS-c10mg | PPA-WL-MS10-P00703 | 99.2% | 07/19/2026 | ID + Purity + Mass |
| HelixBridge | Reta10mg•User Submitted | — | 99.38% | 07/18/2026 | ID + Purity + Mass |